FDA Drug Application (208524) for BELVIQ XR by EISAI INC

Back to FDA Applications sponsored by EISAI INC

Application Number208524
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBELVIQ XR
Active IngredientLORCASERIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient LORCASERIN HYDROCHLORIDE2


Back to FDA Applications sponsored by EISAI INC